Search results
Optimising Treatment of HF
Video Series
Added:
3 years ago
Cardiovascular diseases (CVD) are a major cause of complications in pregnancies worldwide, and can be largely attributed to increased cardiovascular risk factors, such as obesity and hypertensive disorders.1 Today, up to 4% of all pregnancies are complicated by CVD, with increasing frequency.2 Cardiomyopathies – whether inherited or acquired – represent the leading cause of maternal morbidity and…
View more
Added:
1 year ago
This video series is dedicated to the adoption of patient-reported outcomes (PROs) and initiation of guideline-directed medical therapy (GDMT) in daily practice.
In this second discussion of the series,Prof Giuseppe Rosano(St George’s University Medical School, London, UK) andDr Biykem Bozkurt (Baylor College of Medicine, Texas, US) consider how we can be personalising our approach to the…
View more
Added:
3 years ago
In 1616, Sir William Harvey was the first person to describe the importance of right ventricular function.1 However, the right ventricle (RV) has received little attention in the past, with cardiology dealing mostly with the diseases of the left ventricle (LV) and their potential treatment. Since the early 1950s, however, the prognostic significance of RV function has been recognised in several…
View more
Treatment of the Diabetic Heart Failure Patient
Added:
3 years ago
Video Series
Added:
1 year ago
This video series is dedicated to the adoption of patient-reported outcomes (PROs) and initiation of guideline-directed medical therapy (GDMT) in daily practice.
In this first discussion,Prof Andrew Coats (Heart Research Institute, Sydney, AU) and Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, Kansas City, US) address how to optimise clinical success using foundational…
View more
Added:
3 years ago
Acute heart failure (AHF) presents symptoms primarily the result of pulmonary congestion due to elevated left ventricular (LV) filling pressures with or without reduced ejection fraction (EF). Common precipitating pathology includes coronary artery disease (CAD), hypertension and valvular heart diseases, in addition to other noncardiac conditions, such as diabetes, anaemia and kidney dysfunction…
View more
Added:
6 years ago
Summary
This Satellite Symposium - Experts on the Spot session titled ‘Optimising treatment of heart failure – where are we today?’ was moderated by Frank Ruschitzka. This session provided delegates the opportunity to ask questions to the expert faculty panelists; John McMurray and John Teerlink, following the two Novartis-sponsored Satellite Symposia on acute and chronic heart failure at ESC…
View more
Added:
11 months ago
ESC-HFA 23 — We are joined by Prof Marianna Fontana (University College London, UK), as she outlines the key findings from the phase 3 APOLLO-B study (Alnylam Pharmaceuticals) (NCT03997383).
APOLLO-B investigated the use of patisiran, a transthyretin-directed small interfering RNA, in a cohort of patients with cardiac amyloidosis. 360 patients were enrolled in the trial and were randomized 1:1…
View more
Added:
3 years ago
Central sleep apnoea (CSA) occurs in approximately one-third of patients with HF and is associated with a significant increase in morbidity and mortality compared to HF patients without CSA.1–3 CSA results in intermittent hypoxia and activation of the renin–angiotensin system, which contributes to worsening HF.4 Symptoms such as fatigue and difficulty concentrating often overlap with the effects…
View more
